lystn

ONS member Donna Bydlon, BSN, RN, OCN®, network director of infusion services at St. Luke's University Hospital and Health Network in Bethlehem, PA, and member of the Greater Lehigh Valley ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss monoclonal antibodies to treat cancer and COVID-19 and considerations for nurses. Editor’s note: After we released this episode, the U.S. Food and Drug Administration (FDA) revoked its emergency use authorization (EUA) for bamlanivimab as a single agent for COVID-19. FDA issued a new EUA permitting bamlanivimab plus etesevimab for COVID-19. The information in this episode still applies to the new EUA. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by February 26, 2023. The planners and faculty for this episode have no conflicts to disclose, and the episode has no commercial support. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Episode Notes Check out these resources from today’s episode: Complete this evaluation for free NCPD. ONS Voice article: COVID-19 Drug Reference Sheet: Bamlanivimab and Etesevimab Oncology Nursing Forum article: Administration of Subcutaneous Monoclonal Antibodies in Patients With Cancer ONS/ASCO Chemotherapy Administration Safety Standards ONS/ONCC Chemotherapy Immunotherapy Certificate Course ONS Standard for Educating Nurses Who Administer Chemotherapy and Biotherapy Lilly National Cancer Institute’s dictionary of cancer terms Regeneron’s casirivimab and imdevimab combination